Phase Ι/Π Study of Stem Cell Therapy in Patients With Autism View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2009-2011

ABSTRACT

Autism is one of those disorders in Autism spectrum disorders (ASD), which characterized by social interaction abnormalities, impaired verbal and non-verbal communication, and repetitive, obsessive behavior, while the therapeutic effect of current treatments remains limited progress .Neural hypoperfusion and immune deregulation are the two key pathologies associated with Autism. Human umbilical cord mesenchymal stem cells (hUC-MSCs) and human cord blood mononuclear cells (hCB-MNCs) have been shown to have the ability to modulate the immune response and enhance angiogenesis, suggesting the novel and promising therapeutic strategy. In this study, the safety and efficacy of hUC-MSCs and hCB-MNCs transplantation will be evaluated in patients with Autism. Detailed Description To investigate the safety and efficacy of human cord blood mononuclear cells and human umbilical cord mesenchymal stem cells transplantation in patients of Autism. More... »

URL

https://clinicaltrials.gov/show/NCT01343511

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3053", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "Autism is one of those disorders in Autism spectrum disorders (ASD), which characterized by social interaction abnormalities, impaired verbal and non-verbal communication, and repetitive, obsessive behavior, while the therapeutic effect of current treatments remains limited progress .Neural hypoperfusion and immune deregulation are the two key pathologies associated with Autism. Human umbilical cord mesenchymal stem cells (hUC-MSCs) and human cord blood mononuclear cells (hCB-MNCs) have been shown to have the ability to modulate the immune response and enhance angiogenesis, suggesting the novel and promising therapeutic strategy. In this study, the safety and efficacy of hUC-MSCs and hCB-MNCs transplantation will be evaluated in patients with Autism.\n\nDetailed Description\nTo investigate the safety and efficacy of human cord blood mononuclear cells and human umbilical cord mesenchymal stem cells transplantation in patients of Autism.", 
    "endDate": "2011-05-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT01343511", 
    "keywords": [
      "stem cell therapy", 
      "patient", 
      "Autistic Disorder", 
      "disorder", 
      "Pervasive Child Development Disorder", 
      "abnormality", 
      "non-verbal communication", 
      "Obsessive Behavior", 
      "therapeutic effect", 
      "current treatment", 
      "limited progress", 
      "hypoperfusion", 
      "deregulation", 
      "pathology", 
      "umbilical cord", 
      "MSc", 
      "blood mononuclear cell", 
      "MNCs", 
      "immune response", 
      "angiogenesis", 
      "promising therapeutic strategy", 
      "safety", 
      "efficacy", 
      "transplantation", 
      "mesenchymal stem cell transplantation"
    ], 
    "name": "Phase \u0399/\u03a0 Study of Stem Cell Therapy in Patients With Autism", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT01343511"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:24", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00010.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.460015.6", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.489423.0", 
        "type": "Organization"
      }
    ], 
    "startDate": "2009-03-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "sg:pub.10.1186/1479-5876-11-196", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010406183", 
          "https://doi.org/10.1186/1479-5876-11-196"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT01343511"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT01343511'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT01343511'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT01343511'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT01343511'


 

This table displays all metadata directly associated to this object as RDF triples.

50 TRIPLES      16 PREDICATES      42 URIs      34 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT01343511 schema:about anzsrc-for:3053
2 schema:description Autism is one of those disorders in Autism spectrum disorders (ASD), which characterized by social interaction abnormalities, impaired verbal and non-verbal communication, and repetitive, obsessive behavior, while the therapeutic effect of current treatments remains limited progress .Neural hypoperfusion and immune deregulation are the two key pathologies associated with Autism. Human umbilical cord mesenchymal stem cells (hUC-MSCs) and human cord blood mononuclear cells (hCB-MNCs) have been shown to have the ability to modulate the immune response and enhance angiogenesis, suggesting the novel and promising therapeutic strategy. In this study, the safety and efficacy of hUC-MSCs and hCB-MNCs transplantation will be evaluated in patients with Autism. Detailed Description To investigate the safety and efficacy of human cord blood mononuclear cells and human umbilical cord mesenchymal stem cells transplantation in patients of Autism.
3 schema:endDate 2011-05-01T00:00:00Z
4 schema:keywords Autistic Disorder
5 MNCs
6 MSc
7 Obsessive Behavior
8 Pervasive Child Development Disorder
9 abnormality
10 angiogenesis
11 blood mononuclear cell
12 current treatment
13 deregulation
14 disorder
15 efficacy
16 hypoperfusion
17 immune response
18 limited progress
19 mesenchymal stem cell transplantation
20 non-verbal communication
21 pathology
22 patient
23 promising therapeutic strategy
24 safety
25 stem cell therapy
26 therapeutic effect
27 transplantation
28 umbilical cord
29 schema:name Phase Ι/Π Study of Stem Cell Therapy in Patients With Autism
30 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT01343511
31 schema:sdDatePublished 2019-03-07T15:24
32 schema:sdLicense https://scigraph.springernature.com/explorer/license/
33 schema:sdPublisher N2789c5eda989482ca8faf2084cef662c
34 schema:sponsor https://www.grid.ac/institutes/grid.460015.6
35 https://www.grid.ac/institutes/grid.489423.0
36 schema:startDate 2009-03-01T00:00:00Z
37 schema:subjectOf sg:pub.10.1186/1479-5876-11-196
38 schema:url https://clinicaltrials.gov/show/NCT01343511
39 sgo:license sg:explorer/license/
40 sgo:sdDataset clinical_trials
41 rdf:type schema:MedicalStudy
42 N2789c5eda989482ca8faf2084cef662c schema:name Springer Nature - SN SciGraph project
43 rdf:type schema:Organization
44 anzsrc-for:3053 schema:inDefinedTermSet anzsrc-for:
45 rdf:type schema:DefinedTerm
46 sg:pub.10.1186/1479-5876-11-196 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010406183
47 https://doi.org/10.1186/1479-5876-11-196
48 rdf:type schema:CreativeWork
49 https://www.grid.ac/institutes/grid.460015.6 schema:Organization
50 https://www.grid.ac/institutes/grid.489423.0 schema:Organization
 




Preview window. Press ESC to close (or click here)


...